Article
ATR mutation in endometrioid endometrial cancer is associated with poor clinical outcomes.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology - 1 Jul 2009
Zighelboim Israel, Schmidt Amy P, Gao Feng, Thaker Premal H, Powell Matthew A, Rader Janet S, Gibb Randall K, Mutch David G, Goodfellow Paul J
Abstract excerpt
PURPOSE Mutations in the DNA damage response gene ATR (exon 10 A10 mononucleotide repeat) have been previously described in endometrial and other cancers with defective DNA mismatch repair. In vitro studies showed that endometrial cancer cell lines with A10 repeat tract truncating mutations have a failure in the ATR-dependent DNA damage response. Cell lines carrying A10 mutations fail to trigger Chk1 activation...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
